» Articles » PMID: 23495359

Identification and Characterization of a High Vancomycin-Resistant Staphylococcus Aureus Harboring VanA Gene Cluster Isolated from Diabetic Foot Ulcer

Overview
Specialty General Medicine
Date 2013 Mar 16
PMID 23495359
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Staphylococcus aureus is a common cause of human infection, and emergence of vancomycin-resistance S. aureus is a great concern for treatment of methicillin-resistant S. aureus,(MRSA) in recent years (MRSA). Here, we report the isolation of high-level VRSA.

Materials And Methods: S. aureus was isolated from foot ulcer of a diabetic woman in Tehran, Iran. Antibiotic susceptibility was determined according to CLSI guidelines. VanA gene cluster PCR was carried out and PCR amplicon of vanA was sequenced.

Results: S. aureus had high-level vancomycin-resistant (MIC 512 ≥ µg/ml). Patient's history revealed that VRSA isolate was acquired through community transmission. Only vanA, vanR and vanS genes were amplified in our isolate. Sequencing revealed that the vanA sequence had high similarity to the vanA sequence of Tn1546.

Conclusion: Although VRSA infection continues to be rare, isolation of community-acquired VRSA is a significant issue and it needs the efforts of public health authorities.

Citing Articles

Diabetes potentiates the emergence and expansion of antibiotic resistance.

Shook J, Genito C, Darwitz B, Tyson K, Velez A, Bridwell S Sci Adv. 2025; 11(7):eads1591.

PMID: 39937900 PMC: 11817934. DOI: 10.1126/sciadv.ads1591.


Inhibition of the Vancomycin Resistance in in Egypt Using Silver Nanoparticles.

Salah N, Saafan A, Salem E, Rabey H, Alsieni M, Alatawi F Biomed Res Int. 2022; 2022:7380147.

PMID: 35535039 PMC: 9078785. DOI: 10.1155/2022/7380147.


Reduced Susceptibility and Resistance to Vancomycin of Staphylococcus aureus: A Review of Global Incidence Patterns and Related Genetic Mechanisms.

Unni S, Siddiqui T, Bidaisee S Cureus. 2021; 13(10):e18925.

PMID: 34812309 PMC: 8603868. DOI: 10.7759/cureus.18925.


Characterization of biofilm formation and virulence factors of isolates from paediatric patients in Tehran, Iran.

Kadkhoda H, Ghalavand Z, Nikmanesh B, Kodori M, Houri H, Taghizadeh Maleki D Iran J Basic Med Sci. 2020; 23(5):691-698.

PMID: 32742608 PMC: 7374987. DOI: 10.22038/ijbms.2020.36299.8644.


Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.

Shariati A, Dadashi M, Moghadam M, van Belkum A, Yaslianifard S, Darban-Sarokhalil D Sci Rep. 2020; 10(1):12689.

PMID: 32728110 PMC: 7391782. DOI: 10.1038/s41598-020-69058-z.


References
1.
Jung W, Hong S, Lim J, Lim S, Kwon N, Kim J . Phenotypic and genetic characterization of vancomycin-resistant enterococci from hospitalized humans and from poultry in Korea. FEMS Microbiol Lett. 2006; 260(2):193-200. DOI: 10.1111/j.1574-6968.2006.00311.x. View

2.
. Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep. 2002; 51(26):565-7. View

3.
Whitener C, Park S, Browne F, Parent L, Julian K, Bozdogan B . Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis. 2004; 38(8):1049-55. DOI: 10.1086/382357. View

4.
Saha B, Singh A, Ghosh A, Bal M . Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol. 2007; 57(Pt 1):72-79. DOI: 10.1099/jmm.0.47144-0. View

5.
Woodford N, Adebiyi A, Palepou M, Cookson B . Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother. 1998; 42(3):502-8. PMC: 105489. DOI: 10.1128/AAC.42.3.502. View